Medication info
Pitavaron Tablets (Pitavastatin Calcium)

Pitavaron Tablets (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
Very light yellowish-red round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201802146 · Approved 2018.05.23 · Insurance code 653404040

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1–2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goals, and patient response, adjust the dose as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this medicine is maintained with continued use.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apolipoprotein B
  • elevated triglyceride levels.
View approved original text

This medication lowers total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia while raising HDL cholesterol levels. It is effective when used in conjunction with dietary measures and aids in the management of dyslipidemia. In other words, it is a medication that contributes to the prevention of cardiovascular diseases by improving blood lipid levels.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1–2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goals, and patient response, adjust the dose as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this medicine is maintained with continued use.

Precautions

This medicine should not be used by individuals who have had allergic reactions to specific components. Patients with impaired liver function or persistently high liver enzyme levels of unclear origin should not take this medication. Individuals with severe liver disorders, bile duct obstruction, or cholestasis should avoid this medicine as well. It should not be used concomitantly by those taking the medication cyclosporine. Patients with myopathy, those who are pregnant or may become pregnant, and nursing mothers should not take this medication. Safety and efficacy have not been established in children, so it should not be used in that population. Additionally, individuals with lactose intolerance or certain genetic disorders should not use this medication. Patients with impaired kidney function should be cautious, as muscle damage and deterioration in kidney function may occur when this medication is used with other specific drugs. Those with poor liver function or excessive alcohol consumption, hypothyroidism, or genetic muscle diseases should use this medication carefully. Special attention is needed for elderly patients and those with severe muscular dystrophy when taking this medication. Various side effects such as muscle pain, weakness, abdominal pain, rash, itching, etc., may occur during treatment; therefore, patients should consult medical professionals immediately if they experience symptoms. Particularly, if muscle-related symptoms or liver dysfunction are suspected, treatment should be discontinued and laboratory tests should be performed. This medication can cause elevated liver enzyme and muscle enzyme levels in blood tests, thereby necessitating regular examinations. There may be drug interactions with this medication that can increase the risk of side effects when taken with certain other drugs; hence, patients must inform their healthcare provider about the medications they are taking. Elderly patients may experience side effects more easily due to decreased bodily function, and dosage adjustments may be needed. Pregnant or breastfeeding women should not take this medication as it may harm the fetus or baby. This medicine has not been proven safe for children, so it should not be used. Medicines should be stored out of reach of children, and it is important to keep them in their original containers instead of transferring to different ones.

Side effects

  • Abdominal pain
  • rash
  • lethargy
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 81 more
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • neutropenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • increased frequency of urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • loss of strength
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid level
  • increased serum potassium and phosphorus
  • taste disturbance
  • lethargy
  • positive antinuclear antibody
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy
  • severe muscle weakness
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • skin tingling
  • insomnia
  • loss of appetite
  • hypertension
  • chest discomfort
  • weakness
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container that can block light, at a temperature between 1 and 30 degrees Celsius at room temperature. Proper storage helps maintain the efficacy of the medication and prevents degradation.

Appearance and packaging

Appearance

Very light yellowish-red round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.